ANITA JOTHY: Open Payments
NPI 1316268626 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,358 in 60 payments from 10 companies in 2025. Trend: 2023 $125 · 2024 $30 · 2025 $1,358
Food & beverage: $1,358
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $302 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $276 |
| ABBVIE INC. | 9 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $189 |
| Janssen Pharmaceuticals, Inc | 3 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Corium, LLC | 1 | $20 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, TRINTELLIX, SPRAVATO, COBENFY, FANAPT, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
